Gemcitabine and oxaliplatin with or without rituximab in relapsed or refractory post-transplant lymphoproliferative disorder following renal transplantation: a single centre experience
Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of immunosuppression following solid organ transplant (SOT), associated with significant morbidity and mortality [1]. Typi...
Authors
- Victoria S. Warbey (ORCID: https://orcid.org/0000-0002-7141-2139)
- Karen Stanley (ORCID: https://orcid.org/0009-0000-6788-9332)
- Mark Ong (ORCID: https://orcid.org/0000-0001-6354-8207)
- Ho Pui Jeff Lam (ORCID: https://orcid.org/0000-0002-5732-2882)
- Sarah Natas
- J.L. Brady (ORCID: https://orcid.org/0000-0002-5622-5503)
- Zaid Viney
- Anna C. Green (ORCID: https://orcid.org/0000-0002-1241-4230)
- Suzanne O. Arulogun (ORCID: https://orcid.org/0000-0001-5151-4990)
- Paul A. Fields (ORCID: https://orcid.org/0000-0002-3189-6298)
- Mary Gleeson (ORCID: https://orcid.org/0000-0001-6915-9878)
- Craig Lennie
- Yurina Miki (ORCID: https://orcid.org/0000-0001-7331-0382)
- Paramit Chowdhury
- Hema Verma
- Lisa Yuen
- George Mikhaeel
- Mina Mansy
Institutions
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-10-28
- DOI
- https://doi.org/10.1080/10428194.2026.2740286
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00